Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer

Table 2

Correlation between percentage of CD44+ EOC stem cells and response to first-line carboplatin/paclitaxel treatment. Groups are classified based on their CD44 expression as tumors containing less than 20% CD44 positive (>20%) or more than 20% CD44 positive cells (<20%).

	Percentage of CD44+ EOC stem cells
	<20% CD44 Cells (𝑛=84)	>20% CD44 Cells (𝑛=15)	𝑃
			0.06
CR + PR; (𝑛=87)	76 (90%)	11 (73%)
SD + PD; (𝑛=12)	8 (10% )	4 (27%)